Augmented Nurse Care Management in CKD Stages 4 to 5: A Randomized Trial

被引:44
|
作者
Fishbane, Steven [1 ,2 ]
Agoritsas, Sofia [1 ,2 ]
Bellucci, Alessandro [1 ,2 ]
Halinski, Candice [1 ,2 ]
Shah, Hitesh H. [1 ,2 ]
Sakhiya, Vipul [1 ,2 ]
Balsam, Leah [3 ]
机构
[1] North Shore Univ Hosp, Dept Med, Div Kidney Dis & Hypertens, Great Neck, NY USA
[2] Long Isl Jewish Med Ctr, Northwell Sch Med, Great Neck, NY USA
[3] Nassau Univ, Med Ctr, Dept Med, Div Nephrol, E Meadow, NY USA
关键词
Chronic kidney disease (CKD); care management; peritoneal dialysis (PD); kidney transplantation; home dialysis; medical informatics; hospitalization; transition of care; late-stage CKD; renal replacement therapy (RRT); RRT modality; nurse care manager; vascular access; patient education; randomized controlled trial (RCT);
D O I
10.1053/j.ajkd.2017.02.366
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Outcomes for patients with late-stage chronic kidney disease (CKD) in the United States are suboptimal. There is poor education and preparation for end-stage kidney disease, as well as a high rate of hospitalization in this group of patients. Study Design: A randomized, parallel-group, 2-arm, controlled trial. Setting & Participants: The study was conducted at 3 sites: a clinic of an academic medical center, a public hospital academic clinic, and a community-based private practice. All participants had late-stage CKD (stages 4-5 CKD). Patients were excluded only if they had significant cognitive impairment. Intervention: The care management intervention involved nurse care manager coordination aided by the use of a disease-based informatics system for monitoring patients' clinical status, enhancing CKD education, and facilitating preparation for end-stage kidney disease. The comparison control group received usual late-stage CKD care alone. Outcomes: The primary outcome was rate of hospitalization. Measurements: Rates of preemptive transplantation, home dialysis, hemodialysis (HD) starts without a hospitalization, and HD therapy initiation rates with catheters or with functioning accesses. Results: 130 patients were randomly assigned. The hospitalization rate was significantly lower in the intervention group versus controls: 0.61 versus 0.92 per year, respectively (incidence rate ratio, 0.66; 95% CI, 0.43-0.99; P = 0.04). Peritoneal dialysis or preemptive transplantation was the initial end-stage kidney disease treatment in 11 of 30 (37%) participants receiving the intervention versus 3 of 29 (10%) receiving usual care. Among HD starts, treatment was initiated without hospitalization in 11 of 19 (58%) participants in the intervention group versus 6 of 26 (23%) in the control group. At the time of HD therapy initiation, a catheter was present in 7 of 19 (37%) participants in the intervention group versus 18 of 26 (69%) in the control group. A functioning arteriovenous access was in place in 10 of 19 (53%) participants in the intervention group and 7 of 26 (27%) in the control group Limitations: Moderate sample size, limited geographic scope. Conclusions: The augmented nurse care management intervention resulted in reduced hospitalizations in late-stage CKD and there were suggestions of improved end-stage kidney disease preparation. Given suboptimal outcomes in late-stage CKD, care management interventions could potentially improve patient outcomes. (C) 2017 by the National Kidney Foundation, Inc.
引用
收藏
页码:498 / 505
页数:8
相关论文
共 50 条
  • [1] Randomized controlled trial of nurse care management for heart failure
    DeBusk, RF
    Miller, NH
    Parker, KM
    Bandura, A
    Kraemer, H
    Cher, D
    West, J
    Greenwald, G
    CIRCULATION, 2002, 106 (19) : 568 - 568
  • [2] Management of Osteoporosis in CKD Stages 3 to 5
    Gordon, Patricia L.
    Frassetto, Lynda A.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 55 (05) : 941 - 956
  • [3] Electronic Decision Support for Management of CKD in Primary Care: A Pragmatic Randomized Trial
    Peralta, Carmen A.
    Livaudais-Toman, Jennifer
    Stebbins, Marilyn
    Lo, Lowell
    Robinson, Andrew
    Pathak, Sarita
    Scherzer, Rebecca
    Karliner, Leah S.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 76 (05) : 636 - 644
  • [4] Alcohol-Related Nurse Care Management in Primary Care A Randomized Clinical Trial
    Bradley, Katharine A.
    Bobb, Jennifer F.
    Ludman, Evette J.
    Chavez, Laura J.
    Saxon, Andrew J.
    Merrill, Joseph O.
    Williams, Emily C.
    Hawkins, Eric J.
    Caldeiro, Ryan M.
    Achtmeyer, Carol E.
    Greenberg, Diane M.
    Lapham, Gwen T.
    Richards, Julie E.
    Lee, Amy K.
    Kivlahan, Daniel R.
    JAMA INTERNAL MEDICINE, 2018, 178 (05) : 613 - 621
  • [5] Paricalcitol Versus Ergocalciferol for Secondary Hyperparathyroidism in CKD Stages 3 and 4: A Randomized Controlled Trial
    Kovesdy, Csaba P.
    Lu, Jun L.
    Malakauskas, Sandra M.
    Andress, Dennis L.
    Kalantar-Zadeh, Kamyar
    Ahmadzadeh, Shahram
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2012, 59 (01) : 58 - 66
  • [6] Effect of Alendronate on Vascular Calcification in CKD Stages 3 and 4: A Pilot Randomized Controlled Trial
    Toussaint, Nigel D.
    Lau, Kenneth K.
    Strauss, Boyd J.
    Polkinghorne, Kevan R.
    Kerr, Peter G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (01) : 57 - 68
  • [7] Lanthanum Carbonate Reduces Phosphorus Burden in Patients with CKD Stages 3 and 4: A Randomized Trial
    Sprague, Stuart M.
    Abboud, Hanna
    Qiu, Ping
    Dauphin, Matthew
    Zhang, Pinggao
    Finn, William
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 4 (01): : 178 - 185
  • [8] Phosphorus Additives and Albuminuria in Early Stages of CKD: A Randomized Controlled Trial
    Chang, Alex R.
    Miller, Edgar R., III
    Anderson, Cheryl A.
    Juraschek, Stephen P.
    Moser, Melissa
    White, Karen
    Henry, Bobbie
    Krekel, Caitlin
    Oh, Susan
    Charleston, Jeanne
    Appel, Lawrence J.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2017, 69 (02) : 200 - 209
  • [9] A Randomized Multicenter Trial of Paricalcitol versus Calcitriol for Secondary Hyperparathyroidism in Stages 3-4 CKD
    Coyne, Daniel W.
    Goldberg, Seth
    Faber, Mark
    Ghossein, Cybele
    Sprague, Stuart M.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2014, 9 (09): : 1620 - 1626
  • [10] Preparation of the Dialysis Access in Stages 4 and 5 CKD
    Moist, Louise M.
    Al-Jaishi, Ahmed A.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2016, 23 (04) : 270 - 275